ACIU
Price
$2.01
Change
-$0.06 (-2.90%)
Updated
Jun 27 closing price
Capitalization
202.61M
39 days until earnings call
ARCT
Price
$13.33
Change
-$1.08 (-7.49%)
Updated
Jun 27 closing price
Capitalization
361.25M
44 days until earnings call
Interact to see
Advertisement

ACIU vs ARCT

Header iconACIU vs ARCT Comparison
Open Charts ACIU vs ARCTBanner chart's image
AC Immune SA
Price$2.01
Change-$0.06 (-2.90%)
Volume$129.67K
Capitalization202.61M
Arcturus Therapeutics Holdings
Price$13.33
Change-$1.08 (-7.49%)
Volume$1.2M
Capitalization361.25M
ACIU vs ARCT Comparison Chart in %
Loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACIU vs. ARCT commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Buy and ARCT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ACIU: $2.01 vs. ARCT: $13.32)
Brand notoriety: ACIU and ARCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 106% vs. ARCT: 235%
Market capitalization -- ACIU: $202.61M vs. ARCT: $361.25M
ACIU [@Biotechnology] is valued at $202.61M. ARCT’s [@Biotechnology] market capitalization is $361.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileARCT’s FA Score has 0 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • ARCT’s FA Score: 0 green, 5 red.
According to our system of comparison, ARCT is a better buy in the long-term than ACIU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 5 TA indicator(s) are bullish while ARCT’s TA Score has 5 bullish TA indicator(s).

  • ACIU’s TA Score: 5 bullish, 5 bearish.
  • ARCT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ARCT is a better buy in the short-term than ACIU.

Price Growth

ACIU (@Biotechnology) experienced а +7.13% price change this week, while ARCT (@Biotechnology) price change was +8.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

ACIU is expected to report earnings on Aug 06, 2025.

ARCT is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARCT($361M) has a higher market cap than ACIU($203M). ARCT YTD gains are higher at: -21.509 vs. ACIU (-25.407). ACIU has higher annual earnings (EBITDA): -49.71M vs. ARCT (-63.92M). ARCT has more cash in the bank: 217M vs. ACIU (146M). ACIU has less debt than ARCT: ACIU (5.18M) vs ARCT (42.7M). ARCT has higher revenues than ACIU: ARCT (131M) vs ACIU (28.3M).
ACIUARCTACIU / ARCT
Capitalization203M361M56%
EBITDA-49.71M-63.92M78%
Gain YTD-25.407-21.509118%
P/E RatioN/AN/A-
Revenue28.3M131M22%
Total Cash146M217M67%
Total Debt5.18M42.7M12%
FUNDAMENTALS RATINGS
ACIU vs ARCT: Fundamental Ratings
ACIU
ARCT
OUTLOOK RATING
1..100
7513
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
48
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
5549
P/E GROWTH RATING
1..100
85100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARCT's Valuation (48) in the Pharmaceuticals Major industry is in the same range as ACIU (50). This means that ARCT’s stock grew similarly to ACIU’s over the last 12 months.

ARCT's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ACIU (100). This means that ARCT’s stock grew similarly to ACIU’s over the last 12 months.

ARCT's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as ACIU (96). This means that ARCT’s stock grew similarly to ACIU’s over the last 12 months.

ARCT's Price Growth Rating (49) in the Pharmaceuticals Major industry is in the same range as ACIU (55). This means that ARCT’s stock grew similarly to ACIU’s over the last 12 months.

ACIU's P/E Growth Rating (85) in the Pharmaceuticals Major industry is in the same range as ARCT (100). This means that ACIU’s stock grew similarly to ARCT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACIUARCT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 19 days ago
73%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 24 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NQVAX56.66N/A
N/A
Nuveen Multi Cap Value A
FGRSX43.09N/A
N/A
Federated Hermes Intl Leaders R6
VSORX44.52N/A
N/A
Victory Sycamore Small Company Opp R6
BUIEX56.93N/A
N/A
Buffalo Blue Chip Growth Instl Cl
VIKSX11.23N/A
N/A
Virtus KAR Small-Mid Cap Growth I

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with TRDA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
-7.56%
TRDA - ARCT
52%
Loosely correlated
-1.57%
ABCL - ARCT
51%
Loosely correlated
-3.48%
RGNX - ARCT
51%
Loosely correlated
-4.11%
MRNA - ARCT
50%
Loosely correlated
-1.38%
RXRX - ARCT
50%
Loosely correlated
-6.94%
More